Neuromuscular Disorders
16
4
5
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (16)
Wearable Sensors to Detect Atypical Muscle Activation in Young Infants
Relation Between Muscle Architecture and Functional Ability in Children With Duchenne Muscular Dystrophy
Impact Study on Users of Upper Limb Assistive Devices
Efficacy and Usability of the EXPLORER Exoskeleton in Children With Neurodevelopmental Disorders in Natural Environments
Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain
Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorders.
Safety and Usability of the EXPLORER Exoskeleton in Adults With Neuromuscular Diseases
Bidirectional Tuning of the AFO Stiffness
Response to NonInvasive Mechanical Ventilation According to the Breathing Pattern
Myotonia and Muscle Stiffness in NMD
Study of Feasibility to Reliably Measure Functional Abilities' Changes in Nonambulant Neuromuscular Patients Without Trial Site Visiting
Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases
Upper Limb Evaluation in Non Ambulatory Patients With Neuromuscular Disorder
Screening Questionnaire for Respiratory Muscle Weakness and Sleep-disordered Breathing in Neuromuscular Disorders
Prospective Cohort Follow-up of French Patients With Profound and Multiple Disabilities: Healthcare Pathways and Quality of Life Among Patients and Their Families
Prospective Follow-up of Patients With Glycogen Storage Disease Type III